￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
The efficacy of platinib in RET fusion-positive metastatic non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The U.S. FDA has accelerated the approval of the oral MET inhibitor tepotinib - Kanghule

2025-10-19 11:44:20

Check Details
Platinib has significant effect in treating RET fusion-positive lung cancer

2025-10-19 11:44:20

Check Details
Where can I buy the new lung cancer drug Platinib? How much does a box cost?

2025-10-19 11:44:20

Check Details
The emergence of tepotinib gives lung cancer patients an additional choice

2025-10-19 11:44:20

Check Details
Is bochitinib effective in non-small cell lung cancer?

2025-10-19 11:44:20

Check Details
Has the new lung cancer-targeted drug Platinib been included in medical insurance?

2025-10-19 11:44:20

Check Details
New drug for lung cancer: MET inhibitor tepotinib

2025-10-19 11:44:20

Check Details
Safety and effectiveness of pocitinib in the treatment of EGFR mutated non-small cell lung cancer

2025-10-19 11:44:20

Check Details
Platinib has good effect on advanced RET fusion-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
How much does a box of the new lung cancer drug Tepotinib cost? Where to buy it?

2025-10-19 11:44:20

Check Details
Is the new lung cancer drug Pozitinib available in China?

2025-10-19 11:44:20

Check Details
Category
相关知识